NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
By J. Arron, M. Winslow, A. Polleri, C. Chang, Hai-Ping Wu, Xin Gao, J. Neilson, Lei Chen, Jeremy J. Heit, Seung K. Kim and 5 more. Nature, 2006
690 citations recorded by the source corpus.
Subfields: Genetics, Molecular Biology, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/6f6abb4b17ef347a38d7ef46dd77d578d4d0b1fb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Molecular Biology
- Jennifer A. Doudna
- Steven Lin
- Feng Zhang
- Lei S. Qi
- P. Hsu
- Haifeng Wang
- Marie La Russa
- Rodolphe Barrangou
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery (2014, methodology): “To test these effects at other genomic loci, we programmed Cas9 RNPs to target the DYRK1 gene, which is important for brain development, autism and Downs Syndrome (Arron et al., 2006; Fotaki et al., 2002; O'Roak et al., 2012).”